Financial intelligence for Asia's healthcare markets
Remember me:

Analysis: When PPP isn’t a welcome answer for healthcare

It is perhaps a curious line in the sand to draw, but the new hospital in Dunedin, the second-largest city in the South Island of New Zealand, is gearing up to be a significant battle in the use of private-public partnership funding in the APAC region.

At the weekend, prime minister Bill English unveiled plans for a new up to NZ$1.4 billion dollar (US$1 billion) hospital in Dunedin, in what will be the largest build of its type in the country’s history. It is also one of the most controversial. This has nothing to do with electioneering, though this charge has been made (traditionally government announcements like this are not made within three months of an election) rather it is because of the way that the hospital will be funded.

“We have been assessing the options around refurbishing the existing site and building a new hospital. The decision has been made to rebuild. This would maximise the opportunity of having a purpose-built, state-of-the-art facility, while also minimising disruption to patients and staff,” said health minister Jonathan Coleman. “The ministry of health is working to secure an appropriate site for the new hospital, with a strong preference for a central city location. Depending on the location the new hospital will be opened in seven to ten years,” he added.

But what set the cat among the pigeons was his comments on how the government planned to fund the rebuild. “Given the size of the project the government will consider all funding options including a private public partnership model,” Coleman said.

It drew an instant and angry response from Association of Salaried Medical Specialists (ASMS), the trade union that represents the professional and industrial interests of just over 4,000 senior salaried doctors and dentists, mostly employed in New Zealand District Health Boards.

“A new public hospital for Dunedin is long overdue and very welcome but it needs to be fully funded by the government instead of allowing private investors to profit at the expense of patient care,” said Ian Powell, ASMS executive director.

“If the government does go down this track in Dunedin, then it would essentially be handing over the keys for one of the country’s biggest public hospitals to private investors to maximise extracting profits for themselves. Much of these profits would come from repayments Southern DHB would be forced to pay out of its increased annual operating expenses,” he added, pointing out that PPP funding models had been tried in the UK and proved “financially disastrous”.

This is not the first time that the ASMS has lobbed against a public private model. Earlier this year it raised concerns about the funding model for a new integrated family medical centre which is planned in Westport to replace the existing Buller Hospital.

“The government is trying to force a public private partnership on the West Coast District Health Board that would take money away from patient care and hand it to third party investors,” said Powell in May. “West Coast senior doctors are distressed and angry about the financial foolishness of this shoddy deal and that money that should be spent on West Coast patients will be siphoned off to pay a third party investor.”

Westport remains controversial. On Friday more than 1,000 people demonstrated against the new medical centre and a protest march is planned for Saturday.

The new NZ$10 million centre will be completed in the first half of 2019.

But with a general election next month, healthcare is emerging as a major topic – between those who believe that healthcare is a core part of government spending, and those who believe that private sector assistance is needed. The outcome will be closely watched.

Posted on: 23/08/2017 UTC+08:00


Medical diagnostic imaging services provider Capitol Health has said that it expects to return to profitability in the next financial year and has upgraded its outlook for the year.
Paragon Care, a leading distributor and manufacturer supplying medical equipment to hospitals, has said that it is “targeting strong growth in 2018 across all key metrics”.
Malaysian medical glove manufacturer Supermax Group has reported a 42.8% jump in Q1 profits to M$27.9 million (US$6.8 million) on revenues that 16% to M$312 million.
At its annual general meeting, international pathology, imaging and medical centres operator Sonic Healthcare reaffirmed guidance for the year. Chief executive Colin Goldschmidt said that the first quarter of the 2019 financial year confirmed expectations that underlying earnings would grow between 6% and 8% on a constant currency basis.
It has been another great quarter for China Cord Blood Corporation (CCBC), the country’s largest provider of cord blood storage and ancillary services. For the second quarter in a row, profits more than doubled. They came in at US$10.2 million.
New Zealand-based medical device manufacturer Fisher & Paykel Healthcare has reported a steady set of first half figures. Profits were up 4% to NZ$81.3 million (US$55.3 million) on revenues that rose 8% to NZ$458.4 million.
Retirement village operator Arvida has reported a 14.5% slump in profits for the first half of the year to NZ$14.5 million (US$9.9 million). At the same time, revenues were up 27.9% to NZ$60 million.
Medical device manufacturer Microport Scientific Corporation plans to acquire the cardiac rhythm management (CRM) business of London-based medical device manufacturer LivaNova for US$190 million.


The promise of a bottom in Singapore’s office market has caused its ranking as an investment market to soar from next-to-bottom last year to third in this year’s “Emerging Trends in Real Estate Asia Pacific 2018” report, a real estate forecast jointly published by the Urban Land Institute (ULI) and PwC.
Kamal Brar, vice president and general manager of Asia Pacific for data software company Hortonworks, looks at how data analytics can provide effective and affordable healthcare in Singapore.
The latest Sun Life Financial Asia Diabetes Awareness Study reveals an alarming knowledge gap in diabetes. A third of Asian women who are or were pregnant in the past three years are unaware of the risk of developing gestational diabetes in pregnancy, while one in seven births in Asia is currently affected by gestational diabetes.
Gan Kim Yong, Singapore’s minister for health, explains why the private sector needs to get behind the National Electronic Health Record System.
Business leaders in Asia Pacific’s healthcare industry are showing urgency in embracing the fourth industrial revolution, according to the Microsoft Asia Digital Transformation Survey. More than three-quarters of them believe that they need to transform to a digital business to enable future growth and yet only a quarter said that they have a full digital strategy in place today.
An agreement for an additional US$15 million funding from the World Bank will be used to expand health and nutrition coverage in the Lao People's Democratic Republic. It is expected to benefit more than 1 million people across 14 provinces.
Bart Van den Mooter, CEO of the TforG Group, looks at the drivers behind the rapid growth in Asia’s medical tourism market.
The ambitious healthcare agenda under Moon Jae-in's liberal presidency will seek to expand national health insurance reimbursement and limit the burden of excessive medical costs, while overhauling the healthcare system. BMI Research looks at the winners and the losers in the presidential agenda.




Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices